News and Comments

The Sky’s The Limit For Micromet’s BiTE Technology’s Capability

  Tuesday, July 19, 2011

Micromet (MITI) added another important collaborator, Amgen (AMGN), to a long list of large and small drug developing companies that are attracted to Micromet’s BiTE technology. Amgen/Micromet agreement looks fair for both. It fits Amgen’s strategy of focusing on adding next-generation products to its pipeline and helps Micromet’s financial requirements during the development of its promising proprietary cancer programs. Amgen wanted to select from among three BiTE-based drugs against three undisclosed solid tumor targets. The giant biotech will pay upfront, milestone, and other payments in a deal that could be worth over $900 million for the two selected drugs, or half of this amount if it selects only one drug, in addition to double-digit royalties in the event of approvals and sales. More...


Recent Postings


Archive


Tags

Sanofi-Aventis (SAN) Agenus (AGEN NANTKWEST (NK) Onyx (ONXX) ARGOS (ARGS) Prolor Biotech (PBTH) Alnylam (ALNY) Prosensa (RNA) Gilead (GILD) Exelixis (EXEL) Multiple Myeloma Tysabri Array Pharmaceuticals (ARRY) Anadys (ANDS) Ridaforolimus IDERA (IDRA) Sarepta (SRPT) HALOZYME (HALO) Cytokinetics (CYTK) LEXICON (LXRX) galapagos (GLPG) ARCA (ABIO) Inovio (INO) Jazz Pharmaceuticals (JAZZ) Xoma (XOMA) Herceptin Akebia Therapeutics (AKAB) Epizyme (EPZM) Human Longevity (HLI) Bellicum (BLCM) SUNESIS PHARMACEUTICALS (SNSS) Roche (ROCHE) CompuGen (CGEN) Vitae Pharmaceuticals (VTAE) GUARDIAN HEALTH NEUROCRINE (NBIX) Idenix (IDIX) Ionis (IONS) Incyte (INCY) Elan (ELN) Endometrial Cancer AGOS (ARGS) KITE (KITE) Spike Therapeutics (ONCE) KERYX (KERX) Telaprevir JOUNCE THERAPEUTICS (JNCE) ISIS (ISIS) SERES THERAPEUTICS (MCRB) C4 Therapeutics Bristol-Myers Squibb (BMY) Sanofi (SNY) Global Cell Therapeutics (GBT) Ziofpharm (ZIOP) Intercept (ICPT) Velcade (bortezomib) Regeneron (REGN) Sequenom (SQNM) Rapamune Theravance (THRX) Intermune (ITMN) Illumina (ILMN) TOKAI (TKAOI) Alder Biopharmaceuticals (ALDR) Theravance Bio Pharma (TBPH) Dendreon (DNDN) Human Genome Sciences (HGSI) PTC Therapeutics (PTCT) SYNTA (SNTA) Amgen (AMGN) Auspex (ASPX) VANDA (VNDA) Revlimid (lenolidamide) JUNO (JUNO) Ariad (ARIA) Genentech Galena (GALE) MODERNA Dynavax (DVAX) ADVENTRIX (ANX) Abbott Laboratories (ABT) Seattle Genetics (SGEN) GlycoMimetics (GLYN) Editas (EDIT) GlaxoSmithKline (GSK) Valeant Pharmaceuticals International (VRX) Anacor (ANAC) ZALTRAP™ Merck (MRK) ABBVIE (ABBV) Mirati Therapeutics (MRTX) Agenus (AGEN) Roche (RHHBY) Ocular Therapeutix (OCUL) Adaptimmune (ADAP) RenenxBio (RGNX) OncoCyte (OCX) Zerenex Sanofi (SNA) INNOVIVA (INVA) PORTOLA (PTLA) Advaxis (ADXS) NOVOCURE (NVCR) CEMPRA (CEMP) Biocryst (BCRX) Trastuzumab-DM1 CRISPR Therapeutics (CRSP) Pluristem (PSTI) AstraZeneca (AZN) Biogen Idec (BIIB) Micromet (MITI) AERIE PHARMACEUTICALS BIOMARIN (BMRN) Aimmune Therapeutics (AIMT) Intrexon (XON) ImmunoGen (IMGN) OSI (OSIP) Vertex (VRTX) REGULUS (RGLS) NEKTAR (NKTR)) Sangamo (SGMO) ACADIA (ACAD) Benlysta (belimumab)